| Literature DB >> 29309411 |
Susanne Wiese1, Lynne Elson2, Hermann Feldmeier1.
Abstract
BACKGROUND: Tungiasis (sand flea disease) is a neglected tropical skin disease caused by female sand fleas (Tunga spp.) embedded in the skin of the host. The disease is common in sub-Saharan Africa and predominantly affects children living in impoverished rural communities. In these settings tungiasis is associated with important morbidity. Whether tungiasis impairs life quality has never been studied.Entities:
Mesh:
Year: 2018 PMID: 29309411 PMCID: PMC5757912 DOI: 10.1371/journal.pntd.0005939
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Interpretation of the tungiasis-related DLQI scores.
| Scores | Assumed impact on patient’s life quality |
|---|---|
| 0–1 | None |
| 2–3 | Small |
| 4–8 | Moderate |
| 9–13 | Large |
| 14–18 | Very large |
Demographic and clinical characteristics of children with tungiasis (n = 50).
| Sex | 50 (100) | 35 (70) | 15 (30) |
| Age (years) | |||
| Median | 8 | 9 | 8 |
| Range | 5–14 | 5–14 | 5–14 |
| Erythema/warmness/oedema | 43 (86) | 29 (83) | 14 (93) |
| Suppuration/ulcer/abscess | 27 (54) | 21 (60) | 6 (40) |
| Local pain (points) | |||
| 0 | 6 (12) | 4 (11) | 2 (13) |
| 1 | 19 (38) | 11 (31) | 8 (53) |
| 2 | 15 (30) | 11 (31) | 4 (27) |
| 3 | 10 (20) | 9 (26) | 1 (7) |
| Itching (points) | |||
| 0 | 3 (6) | 2 (6) | 1 (7) |
| 1 | 32 (64) | 22 (63) | 10 (67) |
| 2 | 9 (18) | 6 (17) | 3 (20) |
| 3 | 6 (12) | 5 (14) | 1 (7) |
| All lesions types | 52.5 (40–81.5) | 59 (41.5–85.5) | 43 (27–75) |
| Viable lesions | 7 (3–12.75) | 8 (4–15.5) | 4 (1–7.5) |
| Non-viable lesions | 12.5 (6–19.8) | 13 (6.5–13) | 9 (4.5–18.5) |
| Manipulated lesions | 33 (25–48.75) | 37 (26–50) | 31 (14–48) |
| SSAT | 10 (7.25–12) | 10 (8–14.5) | 8 (7–10.5) |
| SSCT | 6 (4–7.5) | 6.5 (4–8) | 6 (4.5–6) |
* indicated by the patient using a visual scale; see Material and methods
IQR: interquartile range
SSAT: severity score for acute tungiasis
SSCT: severity score for chronic tungiasis
Tungiasis-related life quality impairment (n = 50).
| Tungiasis-related DLQI-scores | Impact on life quality | N (%) | N (%) | N (%) | P-value |
|---|---|---|---|---|---|
| (0–1 points) | No effect | 2 (4) | 1 (3) | 1 (7) | 0.51 |
| (2–3 points) | Small effect | 9 (18) | 6 (17) | 3 (20) | 1.00 |
| (4–8 points) | Moderate effect | 28 (56) | 19 (54) | 9 (60) | 0.76 |
| (9–13 points) | Large effect | 10 (20) | 8 (23) | 2 (13) | 0.70 |
| (14–18 points) | Very large effect | 1 (2) | 1 (3) | 0 (0) | 1.00 |
Fig 1Distribution of the tungiasis-related DLQI scores (n = 50).
Restriction categories in patients with tungiasis (n = 50).
| Restriction category | N (%) | N (%) | N (%) | P value |
|---|---|---|---|---|
| Sleep disturbances | 43 (86) | 32 (91) | 11 (73) | 0.18 |
| Concentration difficulty | 42 (84) | 30 (86) | 12 (80) | 0.68 |
| Feeling of shame | 38 (76) | 28 (80) | 10 (67) | 0.47 |
| Restriction of leisure activities | 38 (76) | 28 (80) | 10 (67) | 0.47 |
| Walking difficulty | 37 (74) | 26 (74) | 11 (73) | 1.00 |
| Social exclusion | 31 (62) | 21 (60) | 10 (67) | 0.76 |
| Median (IQR) | 6 (4–8) | 6 (4–8.5) | 6 (3.5–8) | 0.41 |
Fig 2Correlation between severity of tungiasis measured by SSAT and the tungiasis-related DLQI (rho = 0.74, p < 0.001); dotted line = regression curve.
Improvement of clinical pathology and of life quality four weeks after treatment (n = 46).
| Category of impairment | N (%) | N (%) | P value |
|---|---|---|---|
| Sleep disturbances | 39 (85) | 34 (74) | 0.332 |
| Concentration difficulty | 39 (85) | 25 (54) | 0.001 |
| Feeling of shame | 34 (74) | 25 (54) | 0.007 |
| Restriction of leisure activities | 35 (76) | 23 (50) | <0.001 |
| Walking difficulty | 34 (74) | 25 (54) | 0.003 |
| Social exclusion | 29 (63) | 24 (52) | 0.087 |
| Median (IQR) | 6 (4–8) | 5 (1.25–6) | <0.001 |
| Median (IQR) | 10 (7.25–12) | 7 (3.25–8) | <0.001 |
Fig 3Correlation between individual decrease in severity of acute tungiasis (Δ SSAT) and decrease in impairment of life quality (Δ tungiasis-related DLQI) after treatment (rho = 0.61, p < 0.001); dotted line = regression curve.